Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Non-alcoholic Fatty Liver Disease (NAFLD)
100%
Gut Microbiota
100%
Prebiotics
33%
NALFD
33%
Liver
16%
Beneficial Effects
16%
Obesity
16%
Chemokines
16%
Human Studies
16%
Bacterial Products
16%
Therapeutic Strategies
16%
Metabolic Syndrome
16%
Toll-like
16%
Randomized Controlled Clinical Trial
16%
Portal Vein
16%
Enteral nutrition
16%
Therapeutic Modalities
16%
Parenteral nutrition
16%
Microbiota
16%
Preventive Strategies
16%
Clinical Consequences
16%
Bacterial Overgrowth
16%
Increased Intestinal Permeability
16%
Intestinal Microbiota
16%
Energy Storage
16%
Obesity Syndromes
16%
Bacterial DNA
16%
Energy Harvesting
16%
Gut-liver Axis
16%
People with Obesity
16%
TLR4
16%
Endotoxin Lipopolysaccharide
16%
TLR9
16%
Medicine and Dentistry
Nonalcoholic Fatty Liver
100%
Gut Microbiota
100%
Gut
33%
Prebiotics
33%
Probiotics
33%
Microflora
33%
Cytokine
16%
Human Study
16%
Toll Like Receptor 4
16%
Endotoxin
16%
Lipopolysaccharide
16%
Metabolic Syndrome
16%
Controlled Clinical Trial
16%
Hepatic Portal Vein
16%
Chemokine
16%
Enteric Feeding
16%
Therapeutic Modality
16%
Parenteral Nutrition
16%
Bacterial Overgrowth
16%
Intestinal Permeability
16%
Toll Like Receptor
16%
Toll Like Receptor 9
16%
Bacterial DNA
16%
Pathogenesis
16%
Pharmacology, Toxicology and Pharmaceutical Science
Nonalcoholic Fatty Liver
100%
Intestine Flora
100%
Chemokine
16%
Cytokine
16%
Human Study
16%
Controlled Clinical Trial
16%
Lipopolysaccharide
16%
Endotoxin
16%
Metabolic Syndrome X
16%
Toll Like Receptor 4
16%
Intestinal Permeability
16%
Toll Like Receptor
16%
Microflora
16%
Toll Like Receptor 9
16%
Bacterial DNA
16%
Pathogenesis
16%
Immunology and Microbiology
Intestine Flora
100%
Probiotic
40%
Chemokine
20%
Cytokine
20%
TLR4
20%
Microflora
20%
Bacterial Overgrowth
20%
Hepatic Portal Vein
20%
TLR9
20%
Toll-Like Receptor
20%